Free Trial
NASDAQ:THMO

ThermoGenesis (THMO) Stock Price, News & Analysis

ThermoGenesis logo

About ThermoGenesis Stock (NASDAQ:THMO)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
961 shs
Market Capitalization
$1 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ThermoGenesis Holdings, Inc. (NASDAQ: THMO) is a biotechnology company that has developed automated technologies for processing, preserving and storing biological materials used in cell-based therapies and regenerative medicine. Its work has primarily focused on systems designed to improve the collection and preparation of therapeutic cells while reducing manual handling.

The company’s product portfolio has historically included the AXP AutoXpress Platform, an automated system for processing cord blood and other cellular products, and the BioArchive System, an automated cryogenic storage and retrieval platform. ThermoGenesis has also offered related consumables and equipment intended for use by cord-blood banks, cell-therapy organizations and medical institutions.

ThermoGenesis has served customers and partners in the United States and international markets, including Europe and Asia. Publicly available information about its current operating activities and leadership is limited, and the company’s products and business focus have changed over time.

AI Generated. May Contain Errors.

Receive THMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ThermoGenesis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

THMO Stock News Headlines

ThermoGenesis Holdings Inc.
The case for $20,000 gold before year end
President Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and America's $40 trillion national debt to a potential surge in gold prices, with some forecasts pointing to $10,000 or even $20,000 gold. Dr. David Eifrig, a 40-year market veteran and former Goldman Sachs Vice President, says an unusual plan involving Trump and two other top officials could fuel the biggest gold bull run in decades. Eifrig has shared his top gold pick tied to this developing story.tc pixel
North American Morning Briefing: Stock Futures, -2-
See More Headlines

THMO Stock Analysis - Frequently Asked Questions

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) issued its quarterly earnings results on Friday, November, 12th. The company reported ($6.75) EPS for the quarter, missing the consensus estimate of ($3.60) by $3.15. The firm had revenue of $3.16 million for the quarter, compared to analyst estimates of $3.06 million.

Shares of ThermoGenesis reverse split on Friday, December 23rd 2022.The 1-45 reverse split was announced on Friday, December 23rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, December 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of THMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ThermoGenesis investors own include FuelCell Energy (FCEL), Teladoc Health (TDOC), Zoom Communications (ZM), Bionano Genomics (BNGO), Co-Diagnostics (CODX), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/12/2021
Today
10/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Laboratory apparatus & furniture
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:THMO
CIK
811212
Employees
25
Year Founded
1986

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$9.61 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.99) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,953,000
Free Float
1,750,000
Market Cap
$1 thousand
Optionable
Not Optionable
Beta
1.08

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:THMO) was last updated on 10/6/2026 by MarketBeat.com Staff.
From Our Partners